Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-22

Clinical Trial Update: A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients

View source ↗

Summary

A prospective trial is evaluating Direct Selective Laser Trabeculoplasty (DSLT) for achieving >20% intraocular pressure reduction without medications at 6 month…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Brian Shafer | Conditions: Primary Open Angle Glaucoma, Glaucoma | Status: RECRUITING